Profitelligence Profitelligence · Filing Ledger Open PFE research →

Form 8-K · Current Report · Filed 2024-07-01

Pfizer Appoints Cyrus Taraporevala to Board of Directors

On June 27, 2024, Pfizer Inc. announced the election of Cyrus Taraporevala to its Board of Directors, effective immediately. Taraporevala, a seasoned executive with a background in investment management and leadership roles at prominent firms like State Street Global Advisors, Fidelity, BNY Mellon, Legg Mason, and Citigroup, was also appointed to the Audit and Compensation Committees. He currently serves on the boards of Shell plc and Bridgepoint Group plc. The announcement, made via press release on July 1, 2024, highlights Taraporevala's extensive experience in financial markets and global operations, which Pfizer believes will contribute to the company's balanced and experienced board.

Filer
Pfizer Inc. PFE · NYSE
Filed
Accession
0000078003-24-000127
CIK
0000078003
Signal
High impactHealthcare

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

Board Member Appointed Key Executive Appointment
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$27.98

Next session

-0.5%

Since filing

-10.6%

Latest close

$25.01

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from PFE reporting the same item, with the next session's move:

Exhibits (1)

About Pfizer Inc.

Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.

Exchange NYSE Industry Drug Manufacturers - General Company website ↗

Never miss another PFE filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts